CAS 261944-46-1

(7R,8R,9R)-7-(2-methoxyethoxy)-2,3-dimethyl-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridin-8-ol

Description:

The chemical substance known as "(7R,8R,9R)-7-(2-methoxyethoxy)-2,3-dimethyl-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridin-8-ol" with CAS number 261944-46-1 is a complex organic compound characterized by its multi-ring structure, which includes an imidazo[1,2-h][1,7]naphthyridine framework. This compound features several functional groups, including a hydroxyl group (-OH) and an ether group (-O-), which contribute to its chemical reactivity and potential biological activity. The presence of multiple methyl groups and a phenyl ring suggests that it may exhibit hydrophobic properties, influencing its solubility and interaction with biological membranes. The stereochemistry indicated by the (7R,8R,9R) configuration suggests specific spatial arrangements that could be crucial for its biological function or pharmacological activity. Overall, this compound may be of interest in medicinal chemistry, particularly in the development of pharmaceuticals targeting specific biological pathways. Further studies would be necessary to elucidate its precise properties and potential applications.

Formula: C₂₁H₂₅N₃O₃

InChI: InChI=1/C21H25N3O3/c1-13-14(2)24-10-9-16-18(21(24)22-13)23-17(15-7-5-4-6-8-15)19(25)20(16)27-12-11-26-3/h4-10,17,19-20,23,25H,11-12H2,1-3H3/t17-,19-,20-/m1/s1

SMILES: Cc1c(C)n2ccc3c(c2n1)N[C@H](c1ccccc1)[C@H]([C@@H]3OCCOC)O

Imidazo[1,2-h][1,7]naphthyridin-8-ol, 7,8,9,10-tetrahydro-7-(2-methoxyethoxy)-2,3-dimethyl-9-phenyl-, (7R,8R,9R)-

CAS: 261944-46-1

Formula: C₂₁H₂₅N₃O₃

Purity: 99%

Molecular weight: 367.4415

Ref: IN-DA002S5T

Soraprazan

CAS: 261944-46-1

Soraprazan

Purity: ≥95%

Molecular weight: 367.44g/mol

Ref: 54-BUP14516

Soraprazan

Controlled Product

CAS: 261944-46-1

Formula: C₂₁H₂₅N₃O₃

Color and Shape: Neat

Molecular weight: 367.442

Ref: TR-S676860

Soraprazan

CAS: 261944-46-1

Soraprazan is a proton pump inhibitor that inhibits the production of stomach acid by blocking the hydrogen-potassium adenosine triphosphatase enzyme. It is used to treat conditions such as gastroesophageal reflux disease, peptic ulcer disease, and Zollinger-Ellison syndrome. Soraprazan has been shown to be effective in reducing gastric acidity in patients with Zollinger-Ellison syndrome. This drug is available in oral dosage forms and can also be administered intravitreal injection for the treatment of retinal diseases, such as diabetic retinopathy. Soraprazan is stable in cell culture and does not undergo chemical degradation.

Purity: Min. 95%

Ref: 3D-FS59620

Soraprazan

CAS: 261944-46-1

BS3 Crosslinker (Bis(sulfosuccinimidyl)suberate) is an ADC linker that can be used to synthesize antibody-coupled active molecules.

Formula: C₂₁H₂₅N₃O₃

Purity: 97.69% - 99.84%

Color and Shape: Solid

Molecular weight: 367.44

Ref: TM-T12977